Evaluation of efficacy of cholecalciferol and silymarin in improving lower urinary tract symptoms of benign prostatic hyperplasia: A double-blind, randomized, controlled trial
In this investigation, combination therapy with cholecalciferol at 50,000 IU/w for 8 weeks and Silymarin at a dosage of 480 mg for 3 months resulted in a notable improvement in the IPSS score, PV, and PVR, as well as both irritative and obstructive symptoms. However, the total PSA and free PSA amounts did not reach a significant difference.
Authors
- Parham Torabinavid (ORCID: https://orcid.org/0009-0002-3684-1728)
- Hamidreza Momeni (ORCID: https://orcid.org/0009-0009-7553-1635)
- Behzad Narouie (ORCID: https://orcid.org/0000-0003-1574-0055)
- Reza Valipour (ORCID: https://orcid.org/0000-0003-2514-4708)
- Negar Radpour (ORCID: https://orcid.org/0009-0004-7399-6774)
- Ali Jowzi
- Amirreza Momeni (ORCID: https://orcid.org/0000-0003-3610-3418)
Institutions
- University of Tehran (IR)
- Islamic Azad University Medical Branch of Tehran (IR)
- Children's Medical Center (IR)
- Zahedan University of Medical Sciences (IR)
- Shahid Beheshti University of Medical Sciences (IR)
Publication Details
- Journal
- Urologia Journal
- Published
- 2024-09-02
- DOI
- https://doi.org/10.1177/03915603241274467
- Citations
- 1
- Primary Topic
- Silymarin and Mushroom Poisoning
- Type
- article
- Field-Weighted Citation Impact
- 0.42